Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 12/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23327788 | 0.89 | APP (0.52) | APPMAPTGLAGAA | |
| SCHEMBL21462584 | 0.87 | APP (0.46) | APPMAPTGLAGAA | |
| SCHEMBL21462403 | 0.86 | APP (0.51) | APPMAPTTP53 | |
| SCHEMBL21462572 | 0.83 | APP (0.46) | APP | |
| SCHEMBL21462795 | 0.82 | PCSK9 (0.46) | MAPTTP53GAA | |
| SCHEMBL21462536 | 0.82 | MAPT (0.42) | APPMAPT | |
| SCHEMBL21462433 | 0.82 | APP (0.50) | APPMAPTLMNATP53GAA | |
| SCHEMBL23263904 | 0.81 | APP (0.53) | APPMAPTLMNATP53GLA | |
| SCHEMBL2055233 | 0.81 | ILK (0.59) | APPGLAGAA | |
| SCHEMBL21462494 | 0.79 | APP (0.52) | APPMAPTLMNATP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636385-B2 | Selective ligands for tau aggregates | SENTONIX, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20210138092-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | CBD SOLUTIONS AB (SE) | 2021-05-13 | — | — | US | claimed |
| EP-3774771-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | Karin&Sten Mortstedt CBD Solutions AB (SE) | 2021-02-17 | — | — | EP | claimed |
| WO-2019197502-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) | 2019-10-17 | — | — | WO | claimed |
| US-12636385-B2 | Selective ligands for tau aggregates | SENTONIX, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20210138092-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | CBD SOLUTIONS AB (SE) | 2021-05-13 | — | — | US | disclosed |
| US-20210138092-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | CBD SOLUTIONS AB (SE) | 2021-05-13 | — | — | US | disclosed |
| EP-3774771-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | Karin&Sten Mortstedt CBD Solutions AB (SE) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019197502-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | KARIN & STEN MORTSTEDT CBD SOLUTIONS AB (SE) | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210138092-A1 | SELECTIVE LIGANDS FOR TAU AGGREGATES | MAPT, PSEN1, PSEN2 | APP 12/4885MAPT 1/4885LMNA 2633/4885 |
| US-12636385-B2 | Selective ligands for tau aggregates | MAPT, PSEN2, PSEN1 | APP 36/4885MAPT 1/4885LMNA 749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.